La bourse est fermée

Gerresheimer AG (GXI.DE)

XETRA - XETRA Prix différé. Devise en EUR
Ajouter à la liste dynamique
98,90-1,10 (-1,10 %)
À la clôture : 05:35PM CEST

Gerresheimer AG

Klaus-Bungert-Strasse 4
Düsseldorf 40468
Germany
49 211 61 81 00
https://www.gerresheimer.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein11 947

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Dietmar SiemssenCEO, Chairman of the Management Board and CEO of Plastics, Devices & Advanced Technologies Division2,17MS.O.1963
Dr. Bernd Metzner Ph.D.CFO & Member of the Management Board1,31MS.O.1970
Dr. Lukas BurkhardtMember of the Management Board1,28MS.O.1979
Ms. Katja SchnitzlerGlobal Senior VP of People & Organization and Member of Supervisory Board108kS.O.1981
Mr. Guido PickertHead of Investor RelationsS.O.S.O.S.O.
Ueli UtzingerGroup Senior Director Marketing & CommunicationS.O.S.O.S.O.
Ms. Carolin NadiloCorporate Director of Investor RelationsS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en EUR.

Description

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Gerresheimer AG en date du 1 avril 2024 est 4. Les scores principaux sont Audit : 5; Société : 5; Droits des actionnaires : 1; Compensation : 2.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.